Aktuellt
SENASTE
Redeye comments on Surgical Science announcing an opportunistic bolt-on deal by offering to acquire all shares in UK-listed Intelligent Ultrasound at an EV/Sales multiple of c0.5x. If completed, the deal would expand Surgical Science’s ultrasound simulation sales from cSEK90m to cSEK222m (2023 pro-forma). We endorse Surgical Science putting some cash to work by acquiring an SME at a reasonable valuation while consolidating another simulation niche. We view the deal as short-term margin-dilutive, though potential synergies and cross-selling might start to reverse that in 2026e.
LÄS MER
